Literature DB >> 21278626

Assessing male condom failure and incorrect use.

Ann Duerr1, Maria F Gallo, Lee Warner, Denise J Jamieson, Andrzej Kulczycki, Maurizio Macaluso.   

Abstract

BACKGROUND: It has not been well established whether common indices of male condom failure are valid predictors of biologically meaningful exposure during condom use.
METHODS: To address this gap, the authors compared self-reported condom malfunctions (i.e., breakage and slippage) and incorrect condom practices to 2 following objective measures of failure: prostate-specific antigen (PSA) detected in vaginal swabs collected after condom use and structural integrity of used condoms. The study, conducted in 2000-2001, evaluated 635 male condoms used by 77 women attending an outpatient, reproductive-health clinic in Birmingham, AL.
RESULTS: Women reported breakage or slippage for 7.9% of condoms; 3.5% of postcoital swabs had moderate or high levels of PSA; and laboratory testing of used condoms revealed breaks (1.1%) and leaks (2.0%). Self-reported breakage and slippage was associated with moderate/high PSA concentrations in postcoital swabs only when the malfunctions were not accompanied by reports of corrective actions to reduce exposure (adjusted odds ratio [aOR], 6.9; 95% confidence interval [CI], 1.8-26.2). Defects observed in postcoital laboratory testing were related to PSA detection (aOR, 8.0; 95% CI, 1.5-42.6). Incorrect practices defined on the condom label were frequent, but not all types were associated with semen exposure. Furthermore, other practices not currently label-defined were associated with semen exposure: touching the tip of the penis with his hands (aOR, 6.2; 95% CI, 2.3-17.0) or with her hands (aOR, 2.8; 95% CI, 1.1-72) before donning the condom.
CONCLUSIONS: Used correctly, male condoms afforded good protection based on objective measures of failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278626     DOI: 10.1097/OLQ.0b013e3182096b62

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  HIV/STI Risk Behavior of Drug Court Participants.

Authors:  Angela A Robertson; Janet S St Lawrence; D Lee McCluskey
Journal:  J Offender Rehabil       Date:  2012-07

2.  Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States.

Authors:  Kimberly K Repp; Carrie M Nielson; Rongwei Fu; Sean Schafer; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Luisa L Villa; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-03-06       Impact factor: 5.226

3.  Behavioral Decision Research Intervention Reduces Risky Sexual Behavior.

Authors:  Julie S Downs; Wändi Bruine de Bruin; Baruch Fischhoff; Pamela J Murray
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

4.  Baseline correlates of inconsistent and incorrect condom use among sexually active women in the contraceptive CHOICE Project.

Authors:  Shirley L Shih; Chelsea A Kebodeaux; Gina M Secura; Jenifer E Allsworth; Tessa Madden; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

5.  A quantitative glycogen assay to verify use of self-administered vaginal swabs.

Authors:  Deborah J Anderson; Joseph A Politch; Jeffrey Pudney; Cecilia I Marquez; Margaret C Snead; Christine Mauck
Journal:  Sex Transm Dis       Date:  2012-12       Impact factor: 2.830

6.  Efficacy of a combined contraceptive regimen consisting of condoms and emergency contraception pills.

Authors:  Rui Zhao; Jun-Qing Wu; Yu-Yan Li; Ying Zhou; Hong-Lei Ji; Yi-Ran Li
Journal:  BMC Public Health       Date:  2014-04-14       Impact factor: 3.295

7.  Performance of Male Condoms When Used With and Without a Silicone Placebo Vaginal Ring-A Randomized, Crossover Trial.

Authors:  Annalene Nel; Mariëtte Malherbe; Neliëtte van Niekerk; Mags Beksinska; Ross Greener; Jennifer Smit; Ron Frezieres; Terri Walsh
Journal:  J Acquir Immune Defic Syndr       Date:  2020-09-01       Impact factor: 3.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.